Opium as a risk factor for early-onset coronary artery disease: Results from the Milano-Iran (MIran) study

PLoS One. 2023 Apr 19;18(4):e0283707. doi: 10.1371/journal.pone.0283707. eCollection 2023.

Abstract

The spreading of opium use poses new health related concerns. In some areas of Asia its use is believed to protect from cardiovascular disorders, such as coronary artery disease (CAD). However, whether opium use has an association with CAD is unclear. We aimed to investigate the association between non-medical opium use and CAD. We set up a case-control analysis, i.e., the Milano-Iran (MIran) study by enrolling consecutive young patients who underwent a coronary angiography at the Tehran Heart Center, between 2004 and 2011. Incident cases with CAD were contrasted with controls for opium use. Relative risks were calculated in terms of odds ratios (ORs) by logistic regression models adjusted for age, sex, cigarette smoking, body mass index, hypertension, hyperlipidaemia, and diabetes. Interaction analyses were performed between opium and major cardiovascular risk factors. 1011 patients with CAD (mean age 43.6 years) and 2002 controls (mean age 54.3 years) were included in the study. Habitual opium users had a 3.8-fold increased risk of CAD (95%CI 2.4-6.2) compared with non-users. The association was strongest for men, with a fully adjusted OR of 5.5 (95%CI 3.0-9.9). No interaction was observed for the combination of opium addiction and hypertension, or diabetes, but an excess in risk was found in opium users with hyperlipidaemia (OR 16.8, 95%CI 8.9-31.7, expected OR 12.2), suggesting supra-additive interaction. In conclusion, despite common beliefs, we showed that non-medical opium use is associated with an increased risk of CAD, even when other cardiovascular risk factors are taken into account.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Coronary Artery Disease* / complications
  • Coronary Artery Disease* / epidemiology
  • Diabetes Mellitus* / chemically induced
  • Humans
  • Hypertension* / chemically induced
  • Hypertension* / complications
  • Hypertension* / epidemiology
  • Iran / epidemiology
  • Male
  • Middle Aged
  • Opioid-Related Disorders* / complications
  • Opioid-Related Disorders* / epidemiology
  • Opium / adverse effects
  • Opium Dependence* / complications
  • Opium Dependence* / epidemiology
  • Risk Factors

Substances

  • Opium

Grants and funding

The study was partially supported by the Italian Ministry of Health (Bando Ricerca Corrente 2022) through the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. Moreover, the Tehran Heart Center and the Università degli Studi di Milano provided logistical and staff support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."